Barclays
MD icon

Barclays’s Pediatrix Medical MD Stock Holding History

Barclays’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,100
Closed -$24K – 5982
2020
Q1 		$24K Buy
2,100
+1,100
+110% +$22.7K ﹤0.01% 5579
2019
Q4 		$28K Buy
+1,000
New +$25.1K ﹤0.01% 5902
2018
Q4 		– Sell
-300
Closed -$14K – 7157
2018
Q3 		$14K Sell
300
-3,400
-92% -$156K ﹤0.01% 6566
2018
Q2 		$160K Sell
3,700
-13,300
-78% -$637K ﹤0.01% 4907
2018
Q1 		$946K Buy
17,000
+16,500
+3,300% +$904K ﹤0.01% 3284
2017
Q4 		$27K Sell
500
-1,200
-71% -$56.6K ﹤0.01% 6136
2017
Q3 		$73K Buy
1,700
+1,200
+240% +$57K ﹤0.01% 5142
2017
Q2 		$30K Buy
+500
New +$29.6K ﹤0.01% 5610
2017
Q1 		– Sell
-500
Closed -$33K – 6887
2016
Q4 		$33K Sell
500
-1,200
-71% -$78.1K ﹤0.01% 5392
2016
Q3 		$113K Buy
+1,700
New +$116K ﹤0.01% 4426
2016
Q2 		– Sell
-1,600
Closed -$102K – 6494
2016
Q1 		$102K Sell
1,600
-1,100
-41% -$73K ﹤0.01% 4344
2015
Q4 		$192K Buy
2,700
+1,100
+69% +$81.4K ﹤0.01% 3938
2015
Q3 		$122K Buy
+1,600
New +$129K ﹤0.01% 4480
2015
Q2 		– Sell
-1,000
Closed -$72K – 7124
2015
Q1 		$72K Buy
+1,000
New +$69.5K ﹤0.01% 5037
2014
Q4 		– Sell
-1,500
Closed -$81K – 7468
2014
Q3 		$81K Buy
1,500
+100
+7% +$5.67K ﹤0.01% 5496
2014
Q2 		$81K Sell
1,400
-1,200
-46% -$70.6K ﹤0.01% 5575
2014
Q1 		$158K Sell
2,600
-3,800
-59% -$221K ﹤0.01% 5020
2013
Q4 		$339K Buy
6,400
+1,400
+28% +$75.1K ﹤0.01% 4464
2013
Q3 		$250K Sell
5,000
-12,800
-72% -$625K ﹤0.01% 4819
2013
Q2 		$815K Buy
+17,800
New +$797K ﹤0.01% 3651

Other funds holding MD

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Public Sector Pension Investment Board (PSP Investments)
Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $45.4B AUM 34.02% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Barclays's MD Position: Q3 2026 in Review

Barclays increased its Pediatrix Medical (MD) stake by 90% in Q3 2026, buying an estimated $887K and bringing the position to 71,204 shares worth $1.83M. The position accounts for ﹤0.01% of the portfolio, ranked #2645.

Barclays first reported a position in MD in Q2 2013 and has held it in 54 quarters since. The position peaked at $11.7M in Q2 2019. 166 funds tracked by Wall St. Rank hold MD as of Q3 2026.

  • Barclays held 71,204 shares of Pediatrix Medical worth $1.83M as of Q3 2026.
  • Barclays bought 33,660 Pediatrix Medical shares in Q3 2026, an estimated $887K.
  • Pediatrix Medical made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #2645 holding.
  • Barclays first reported a position in Pediatrix Medical in Q2 2013 and has held it in 54 quarters since.
  • Barclays's Pediatrix Medical position peaked at $11.7M in Q2 2019.
  • 166 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.